Saharti Samah
Department of Pathology, Faculty of Medicine, King Abdulaziz University and King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Cytojournal. 2023 Feb 2;20:3. doi: 10.25259/Cytojournal_9_2022. eCollection 2023.
Fine-needle aspiration (FNA) cytology plays a pivotal role in diagnosing thyroid nodules. Imaging assessment, followed by thyroid lesion sampling, is a widely applied clinical practice. Tissue fragments remnants are retrieved in cell-block providing an adjunct diagnostic tool for histopathology visualization and use of ancillary testing. This study aimed to evaluate whether the auxiliary application of cell-block adds to the diagnostic accuracy of the thyroid FNA.
A total of 252 thyroid FNA cases between (2020 and 2021) were reviewed from patients aged 18-76. Of those, 150 cell-blocks were recovered and examined to assess their utility. Following categories were plotted during cell-blocks revision: (A) Inadequate material retrieved; (B) cell-block shows similar features along with their accompanying smears; and (C) value added to cytology diagnosis when using cell-block.
The distribution of cell-blocks according to the aforementioned classification are as follows: A - non-diagnostic 63%, B - similar observation seen in both preparations 35%, and C - value added to the rendered diagnosis 2%. Hence, the use of cell-block improved cytology diagnosis in only 2% of total cases. Mostly were of immunostains application for diagnosis confirmation.
The non-diagnostic and atypical cytology cases have not been upgraded to a more meaningful category by the incorporation of cell-block performed with the routine non-enhancement random method. On the other hand, cell-blocks contributed generously toward immunostaining application in malignant scenarios.
细针穿刺(FNA)细胞学检查在甲状腺结节诊断中起着关键作用。影像学评估后进行甲状腺病变采样是一种广泛应用的临床实践。在细胞块中获取组织碎片残余物,为组织病理学可视化和辅助检测的使用提供了一种辅助诊断工具。本研究旨在评估细胞块的辅助应用是否能提高甲状腺FNA的诊断准确性。
回顾了2020年至2021年间18至76岁患者的252例甲状腺FNA病例。其中,回收并检查了150个细胞块以评估其效用。在细胞块检查过程中绘制了以下类别:(A)获取的材料不足;(B)细胞块与其附带涂片显示相似特征;(C)使用细胞块时对细胞学诊断有附加值。
根据上述分类,细胞块的分布如下:A - 无法诊断的占63%,B - 两种制片中观察到相似结果的占35%,C - 对诊断有附加值的占2%。因此,细胞块的使用仅在2%的总病例中改善了细胞学诊断。大多数是用于诊断确认的免疫染色应用。
通过采用常规非增强随机方法进行细胞块制作,未将无法诊断和非典型细胞学病例提升到更有意义的类别。另一方面,细胞块在恶性情况下对免疫染色应用有很大贡献。